(1)要約四半期連結純損益計算書

(単位:百万円)

 

 

前第1四半期連結累計期間

(自 2024年4月1日

至 2024年6月30日)

 

当第1四半期連結累計期間

(自 2025年4月1日

至 2025年6月30日)

売上収益

 

473,124

 

505,794

売上原価

 

91,136

 

94,829

売上総利益

 

381,988

 

410,965

 

 

 

 

 

販売費及び一般管理費

 

206,877

 

196,997

研究開発費

 

86,821

 

71,698

無形資産償却費

 

34,992

 

32,767

無形資産譲渡益

 

909

 

3,700

持分法による投資損益

 

1,929

 

1,593

その他の収益

 

4,900

 

4,371

その他の費用

 

10,379

 

21,333

営業利益

 

50,657

 

94,647

 

 

 

 

 

金融収益

 

4,333

 

1,667

金融費用

 

4,495

 

5,898

税引前四半期利益

 

50,495

 

90,416

法人所得税費用

 

12,892

 

21,994

四半期利益

 

37,603

 

68,422

 

 

 

 

 

四半期利益の帰属

 

 

 

 

親会社の所有者

 

37,603

 

68,422

 

 

 

 

 

1株当たり四半期利益

 

 

 

 

基本的1株当たり四半期利益(円)

 

21.00

 

38.22

希薄化後1株当たり四半期利益(円)

 

20.94

 

38.11

 

E00920 45030 アステラス製薬株式会社 Astellas Pharma Inc. 四半期第3号参考様式 [IFRS](連結) IFRS true cte 2025-04-01 2025-06-30 Q1 2026-03-31 2024-04-01 2024-06-30 2025-03-31 1 false false false 45030 2025-07-30 45030 2025-06-30 45030 2025-06-30 jpigp_cor:CapitalSurplusIFRSMember 45030 2025-06-30 jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember 45030 2025-06-30 jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember 45030 2025-06-30 jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember 45030 2025-06-30 jpigp_cor:OtherComponentsOfEquityIFRSMember 45030 2025-06-30 jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember 45030 2025-06-30 jpigp_cor:RetainedEarningsIFRSMember 45030 2025-06-30 jpigp_cor:ShareAcquisitionRightsIFRSMember 45030 2025-06-30 jpigp_cor:ShareCapitalIFRSMember 45030 2025-06-30 jpigp_cor:TreasurySharesIFRSMember 45030 2025-04-01 2025-06-30 45030 2025-04-01 2025-06-30 jpigp_cor:CapitalSurplusIFRSMember 45030 2025-04-01 2025-06-30 jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember 45030 2025-04-01 2025-06-30 jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember 45030 2025-04-01 2025-06-30 jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember 45030 2025-04-01 2025-06-30 jpigp_cor:OtherComponentsOfEquityIFRSMember 45030 2025-04-01 2025-06-30 jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember 45030 2025-04-01 2025-06-30 jpigp_cor:RetainedEarningsIFRSMember 45030 2025-04-01 2025-06-30 jpigp_cor:ShareAcquisitionRightsIFRSMember 45030 2025-04-01 2025-06-30 jpigp_cor:ShareCapitalIFRSMember 45030 2025-04-01 2025-06-30 jpigp_cor:TreasurySharesIFRSMember 45030 2024-06-30 45030 2024-06-30 jpigp_cor:CapitalSurplusIFRSMember 45030 2024-06-30 jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember 45030 2024-06-30 jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember 45030 2024-06-30 jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember 45030 2024-06-30 jpigp_cor:OtherComponentsOfEquityIFRSMember 45030 2024-06-30 jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember 45030 2024-06-30 jpigp_cor:RetainedEarningsIFRSMember 45030 2024-06-30 jpigp_cor:ShareAcquisitionRightsIFRSMember 45030 2024-06-30 jpigp_cor:ShareCapitalIFRSMember 45030 2024-06-30 jpigp_cor:TreasurySharesIFRSMember 45030 2025-03-31 45030 2025-03-31 jpigp_cor:CapitalSurplusIFRSMember 45030 2025-03-31 jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember 45030 2025-03-31 jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember 45030 2025-03-31 jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember 45030 2025-03-31 jpigp_cor:OtherComponentsOfEquityIFRSMember 45030 2025-03-31 jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember 45030 2025-03-31 jpigp_cor:RetainedEarningsIFRSMember 45030 2025-03-31 jpigp_cor:ShareAcquisitionRightsIFRSMember 45030 2025-03-31 jpigp_cor:ShareCapitalIFRSMember 45030 2025-03-31 jpigp_cor:TreasurySharesIFRSMember 45030 2024-04-01 2024-06-30 45030 2024-04-01 2024-06-30 jpigp_cor:CapitalSurplusIFRSMember 45030 2024-04-01 2024-06-30 jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember 45030 2024-04-01 2024-06-30 jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember 45030 2024-04-01 2024-06-30 jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember 45030 2024-04-01 2024-06-30 jpigp_cor:OtherComponentsOfEquityIFRSMember 45030 2024-04-01 2024-06-30 jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember 45030 2024-04-01 2024-06-30 jpigp_cor:RetainedEarningsIFRSMember 45030 2024-04-01 2024-06-30 jpigp_cor:ShareAcquisitionRightsIFRSMember 45030 2024-04-01 2024-06-30 jpigp_cor:ShareCapitalIFRSMember 45030 2024-04-01 2024-06-30 jpigp_cor:TreasurySharesIFRSMember 45030 2024-03-31 45030 2024-03-31 jpigp_cor:CapitalSurplusIFRSMember 45030 2024-03-31 jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember 45030 2024-03-31 jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember 45030 2024-03-31 jpigp_cor:FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember 45030 2024-03-31 jpigp_cor:OtherComponentsOfEquityIFRSMember 45030 2024-03-31 jpigp_cor:RemeasurementsOfDefinedBenefitPlansIFRSMember 45030 2024-03-31 jpigp_cor:RetainedEarningsIFRSMember 45030 2024-03-31 jpigp_cor:ShareAcquisitionRightsIFRSMember 45030 2024-03-31 jpigp_cor:ShareCapitalIFRSMember 45030 2024-03-31 jpigp_cor:TreasurySharesIFRSMember iso4217:JPY iso4217:JPY xbrli:shares xbrli:pure